gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NASDAQ · MMSIHealthcareSurgical Instruments

Merit Medical Systems Inc (MMSI)

$90.67+7.74%
Close Nov 4, 2026 · split-adjusted
Nov 2, 2026$84.78▼ 2.93% in range
Nov 3, 2025Low $60.31 · High $94.20Nov 2, 2026
What changed · written from our data
As of Nov 4, 2026

Merit Medical Systems closed at $90.67 on Nov 4, up 7.74%, 3.7% below its 52-week closing high. Volume of 443.5K shares was 0.58× its 20-day average (below normal).

Split-adjusted performance: +6.7% over one month, +47.1% over six months, +3.8% over one year.

In the quarter ended Sep 30, 2026, revenue was $416.24M, up 8.4% from a year earlier, with a net margin of 10.2%.

Short interest was 3.8M shares at the Oct 15 settlement, up 4.5% from the prior report (6.5% of float, 6.0 days to cover).

Market cap$5.43B59.9M shares
Revenue · quarter$416.2M+8.4% YoY
Diluted EPS$0.70+52.2% YoY
P/E · TTM33.9×P/S 3.4×
Net margin10.2%Gross 48.2%
Dividend yieldNone
52-week range60.31 – 94.20−3.7% from high
Volume443.5K0.58× 20-day avg
Volatility · 60d30.3%Annualised
Short % of float6.5%6.0 days to cover
Net cash-$233.9MCash $503.6M
Next earnings—Not scheduled
Split-adjusted performance
1W −1.7%1M +6.7%3M +3.4%6M +47.1%YTD +2.9%1Y +3.8%3Y +36.4%5Y +32.4%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Surgical Instruments

Percentile among 110 companies (100 = best)

6-month momentum81
Revenue growth48
Net margin79
Value (low P/E)37
Size84

Industry medians: 6-month return −4.4%, revenue growth +8.9%, net margin −8.2%, P/E 29.7×.

Short interest

Details →
Shares short3.8M+4.5% vs prior
Days to cover6.0Settled Oct 15
% of float6.5%
Short vol. 10d57.6%of daily volume

Closest peers by size in Surgical Instruments

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
MMSIMerit Medical Systems$90.67+7.74%+47.1%+8.4%10.2%33.9$5.43B
MMEDMiniMed Group$19.57+3.79%——0.0%—$5.50BCompare
HAEHaemonetics$126.95+5.55%+141.0%+5.6%9.7%60.0$5.78BCompare
HTFLHeartflow$56.31+3.51%+85.9%—−24.6%—$4.90BCompare
TFXTeleflex Incorporated$147.68+5.52%+19.8%+28.9%17.5%—$6.26BCompare
IRTCiRhythm Holdings$136.47+7.99%+15.9%+20.1%−0.2%—$4.50BCompare
ICUIICU Medical$174.50+7.83%+45.9%+0.5%3.5%145.0$4.36BCompare
PLSEPulse Biosciences, Inc Common Stock (DE)$57.25+9.67%+198.0%—−5681.3%—$4.08BCompare
ATRCAtriCure$64.48+6.74%+130.2%+12.8%5.8%310.8$3.28BCompare

News about Merit Medical Systems

All news →
Merit Medical (MMSI) Q3 Earnings and Revenues Beat EstimatesZacks Investment Research · 6d agoNeutralMerit Medical (MMSI) Reports Q3 Earnings: What Key Metrics Have to SayZacks Investment Research · 6d ago▲ PositiveHSIC or MMSI: Which Is the Better Value Stock Right Now?Zacks Investment Research · Oct 6, 2026NeutralZacks Industry Outlook Highlights McKesson, Cardinal Health, Becton, Dickinson, Merit Medical Systems and ProDexZacks Investment Research · Oct 2, 2026▲ PositiveHere's Why You Should Add Merit Medical Stock to Your Portfolio NowZacks Investment Research · Sep 2, 2026▲ Positive

Quick answers

What does Merit Medical Systems do?
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy.
What is MMSI's market cap?
$5.43B, based on the Nov 4 close of $90.67.
What is MMSI's P/E ratio?
33.9× trailing-twelve-month earnings of $160.12M.
Does Merit Medical Systems pay a dividend?
No regular cash dividend has been paid in the last year.
How much of MMSI is sold short?
3.8M shares, 6.5% of float, as of Oct 15, 2026.
What sector is MMSI in?
Healthcare, in the Surgical Instruments industry.

About Merit Medical Systems

Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.

HQ: South Jordan, UT7,500 employeesListed May 10, 1990merit.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology